THE WORST RESEARCH EVER FOUND IN HUMAN HISTORY: LIFE DESTROYER

Intrahospital transfer of critical patients is due to diagnostic, therapeutic objectives or hospitalization in specialized units. This transfer could prompt ...

Neuroprotective treatments in ischemic stroke are focused to reduce the pernicious effect of excitotoxicity, oxidative stress and inflammation. However, those cellular and molecular mechanisms may also have beneficial effects, especially during the late ...

The coronavirus disease 2019 (COVID-19) has rapidly evolved into a worldwide pandemic. Preparing intensive care units (ICU) is an integral part of any pandemic response. In this review, we discuss the key principles and strategies for ICU preparedness. We also describe our initial outbreak measures and share some of the challenges faced. To achieve sustainable ICU services, we propose the need to 1) prepare and implement rapid identification and isolation protocols, and a surge in ICU bed capacity; (2) provide a sustainable workforce with a focus on infection control; (3) ensure adequate supplies to equip ICUs and protect healthcare workers; and (4) maintain quality clinical management, as well as effective communication.

The rapid adoption of virtual care and digital technologies and changing consumer sentiment during the COVID-19 crisis may echo throughout hospital business models long after the pandemic scales down. How can hospitals sustain this accelerated transformation toward the future?

A new model for intra-hospital routing of patients is introduced, considering both client- and management related issues, and it is shown that the different developed model variants are tractable for realistic problem instances of medium-sized hospitals. The aim of this work is to introduce a new model for intra-hospital routing of patients, considering both client- and management related issues. Patients in a hospital have a fixed appointment, such as x-rays or ultrasonic and due to medical reasons they cannot go on their own, so they will be escorted by porters. In our model logistical costs for the usage of porters and patient inconvenience will be minimized. We show that the different developed model variants are tractable for realistic problem instances of medium-sized hospitals.

Intrahospital (within the hospital) patient transportation is widely done by moving the patient to a wheeled stretcher/gurney or transport chair...

The numbers in this report have been updated to reflect the most recent pricing data made available by Sutter Health. While nearly all of...

UPDATED WITH MORE VENDORS: Healthcare IT News offers this listing of telemedicine companies that can help hospitals and other provider organizations deliver quality virtual care.

Helicobacter cinaedi is an emerging pathogen causing bacteraemia and cellulitis. Nosocomial transmission of this microbe has been described, but detailed molecular-epidemiological analyses have not been performed. Here, we describe the results of a multi-step genome-wide phylogenetic analysis of a suspected intra-hospital outbreak of H. cinaedi that occurred in a hospital in Japan. The outbreak was recognized by the infectious control team (ICT) of the hospital as a sudden increase in H. cinaedi bacteraemia. ICT defined this outbreak case based on 16S rRNA sequence data and epidemiological information, but were unable to determine the source and route of the infections. We therefore re-investigated this case using whole-genome sequencing (WGS). We first performed a species-wide analysis using publicly available genome sequences to understand the level of genomic diversity of this under-studied species. The clusters identified were then separately analysed using the genome sequence of a representative strain in each cluster as a reference. These analyses provided a high-level phylogenetic resolution of each cluster, identified a confident set of outbreak isolates, and discriminated them from other closely related but distinct clones, which were locally circulating and invaded the hospital during the same period. By considering the epidemiological data, possible strain transmission chains were inferred, which highlighted the role of asymptomatic carriers or environmental contamination. The emergence of a subclone with increased resistance to fluoroquinolones in the outbreak was also recognized. Our results demonstrate the impact of the use of a closely related genome as a reference to maximize the power of WGS.

Intravenous (IV) medications are given into your vein. Learn about the types of IV administration, their uses, and the risks.

By Harry Adelson, ND ABSTRACT A recent development in regenerative medicine is the use of bone marrow derived mesenchymal stem cells for the treatment of degenerative musculoskeletal conditions such as osteoarthritis. While the use of autologous stem cells is of immediate interest to all practitioners of regenerative medicine, the complexity and expense of the traditional technique more »

Prolotherapy relieves pain by targeting the underlying issue that causes it. Learn how it works to deliver long-lasting pain relief.

Trusted Prolotherapy Specialist serving Upper East Side New York, NY. Contact us at 917-810-4139 or visit us at 112 East 61st Street, New York, NY 10065

Prolotherapy Injections: ☎ (718) 488-0188 Stem cell injections, regenerative procedure. Best back pain treatment, Brooklyn NYC. 2017 New York Top Doctors

Prolotherapy is an injection procedure used to treat connective tissue injuries of the musculoskeletal system that have not healed by either rest or other nonsurgical therapies in order to relieve back pain.

Prolotherapy is an injection-based complementary therapy for common chronic musculoskeletal conditions including tendinopathy, knee osteoarthritis, and low back pain. It involves the injection of irritant solutions into tender ligamentous and tendinous attachments and adjacent joint spaces.

Prolotherapy targets ligament laxity as the cause of chronic joint and spine pain. We at ROSM use prolotherapy to treat an injury by treating a whole region or joint. Visit our locations!

The Journal of Prolotherapy® is a peer-reviewed journal with the purpose of providing the readers with new, cutting-edge information on Prolotherapy, as well as provide a forum for physicians and patients alike to tell their stories. As of 2012, all issues of the Journal of Prolotherapy are FREE to access online. FEATURED ARTICLE FEATURED ARTICLE more »